Clinical Trials Logo

Clinical Trial Summary

In recent years, the number of homeless patients who are accommodated by the SAMU social has increased. These patients are in a situation of financial, but also often social and psychological precariousness. The literature already shows us that precariousness and homelessness are a risk factor for prematurity, but also for the patients themselves, a risk of more frequent recourse to emergency services and of late consultation for advanced pathologies. The objective of this study is to evaluate the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers.


Clinical Trial Description

The hospital of Pontoise is the largest maternity hospital in the department (Val d'Oise, 95) with 4449 births in 2021. It has a type 3 neonatal intensive care unit where approximately 150 premature babies under 32 weeks of age are hospitalized each year, including 80 premature babies under 28 weeks of age. These children require a specific and prolonged follow-up after hospitalization, including medical consultations to evaluate their neurodevelopmental development, but also the prevention of RSV infection (Respiratory Syncitial Virus). In recent years, the number of homeless patients who are accomodated by the SAMU social has increased. These patients are in a precarious financial, but also often social and psychological situation. The literature already shows us that precariousness and homelessness are a risk factor for prematurity, but also for the patients themselves, a risk of more frequent recourse to emergency services and late consultation with advanced pathologies. The aim of this study is to evaluate the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers, by answering the following questions: - What about the follow-up of their very premature child? - How does the department organize itself to ensure optimal follow-up for these patients? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05684419
Study type Observational
Source Hôpital NOVO
Contact
Status Completed
Phase
Start date July 29, 2022
Completion date August 12, 2023

See also
  Status Clinical Trial Phase
Completed NCT03641209 - Extremely Low Gestatonal Age Infants' Paracetamol Study Phase 1/Phase 2
Recruiting NCT04114435 - Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Completed NCT04639583 - Use of NIRS in Preterm Population Born at Altitude N/A
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Completed NCT03504215 - Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health. N/A
Recruiting NCT05615311 - Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm Phase 1/Phase 2
Recruiting NCT04735315 - Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
Recruiting NCT04270240 - A NEW SCORING SYSTEM FOR PREDICTION OF PDA
Completed NCT04535375 - Sonographic QUantification of Venous Circulation In the Preterm Brain N/A
Recruiting NCT05280340 - Anakinra for Preterm Infants Pilot Phase 1/Phase 2
Recruiting NCT05827250 - Vibroacoustic Study of Lung Development in Newborn Infants
Recruiting NCT05824377 - To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation. N/A
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT03261609 - Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.
Active, not recruiting NCT04325308 - Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk N/A
Active, not recruiting NCT04545866 - The Budesonide in Babies (BiB) Trial Phase 3